Aurinia Pharmaceuticals stock price
오리니아 파머슈티컬스NASDAQ:AUPH · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Aurinia Pharmaceuticals last closed at $15.83 (-0.75%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 6.7×. Its overall grade ranks 60 of 739 stocks in Healthcare.
About this company
Aurinia Pharmaceuticals last closed at $15.83 (-0.75%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 60/739
Valuation grade F
Related stocks
- Bristol Myers SquibbCompetitor
루푸스 신장염·자가면역 질환 치료제 영역에서 경쟁 가능한 대형 제약사
- GSKCompetitor
면역·염증 질환 치료제 시장에서 경쟁하는 글로벌 제약사
- RocheCompetitor
면역학·신장질환 관련 파이프라인과 상업화 역량을 가진 대형 경쟁사
About Aurinia Pharmaceuticals
- What technical signals does Aurinia Pharmaceuticals (AUPH) have?
- Aurinia Pharmaceuticals current technical signals: no active technical signal.
- Is Aurinia Pharmaceuticals a cup-and-handle pattern?
- No. Aurinia Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Aurinia Pharmaceuticals?
- Market cap: $2.09B. Trailing 12 months PER: 6.7×. Latest quarter PBR: 3.44×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Aurinia Pharmaceuticals, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).